Latest Peplin news
09-June-09
Peplin Initiates Phase 3 Clinical Trials with PEP005 Gel in AK on Face and Scalp read more
28-May-09
Peplin's Positive Phase II AK Trial Results Published in JAAD read more
17-May-09
Positive Results for Peplin's First Phase III AK Trial read more
15-May-09
Peplin Results for the Quarter Ended 31 March 2009 read more
Michael Spooner BCom ACA MAICD
Non-executive Director
Member of Audit and Risk Committee
Mr. Spooner has served as a member of our board of directors since February 2004. Mr. Spooner is the Executive Chairman of Hunter Immunology Limited, a respiratory and immunology company. Mr. Spooner is also a non-Executive Director and Chairman of Mesoblast Limited, an adult stem cell company, a position he has held since December 2004. Previously, from November 2001 to November 2003, Mr. Spooner served as Managing Director and Chief Executive Officer of Ventracor Limited, an artificial heart company. He has been a partner and director of consulting services for Coopers & Lybrand (now PricewaterhouseCoopers) and PA Consulting Group, respectively.
Mr. Spooner is a chartered accountant and received a Bachelor of Commerce from Queensland University of Technology.
Board of Directors
- Thomas Wiggans, Chairman and Chief Executive Officer
- Eugene Bauer MD, President and Chief Medical Officer
- Joshua Funder PhD, Non-executive Director
- Cherrell Hirst AO, Non-executive Director
- Gary Pace PhD, Non-executive Director
- Michael Spooner, Non-executive Director
- Jim Scopa, Non-executive Director